![]() |
市场调查报告书
商品编码
1938476
药局自动化设备市场-全球产业规模、份额、趋势、机会及预测(依产品、通路、地区及竞争格局划分,2021-2031年)Pharmacy Automation Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Distribution Channel, By Region & Competition, 2021-2031F |
||||||
全球药局自动化设备市场预计将从 2025 年的 57.3 亿美元成长到 2031 年的 96.7 亿美元,复合年增长率为 9.11%。
这些电子机械系统旨在实现关键药物管理流程的自动化,例如药物的储存、包装、分发和回收,从而提高医院和零售环境的营运效率。市场成长的主要驱动力是减少用药错误、应对快速成长的处方笺量以及提高员工生产力的迫切需求。美国卫生系统药剂师协会 (ASHP) 的数据支持其广泛应用,报告显示,到 2024 年,86.1% 的医院将使用自动发药柜作为其维持剂量分发的主要方法。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 57.3亿美元 |
| 市场规模:2031年 | 96.7亿美元 |
| 复合年增长率:2026-2031年 | 9.11% |
| 成长最快的细分市场 | 自动配药系统 |
| 最大的市场 | 北美洲 |
儘管呈现正向趋势,但由于采用机器人系统需要大量资本投入,市场仍面临许多障碍。小规模医疗机构往往因初始成本高昂以及将其整合到现有医院资讯系统方面的技术难题而对采用机器人系统犹豫不决。因此,这些财务和基础设施的挑战仍然存在,阻碍了资源有限环境下的市场扩张和更广泛的应用。
减少用药错误和提高病人安全是推动药局自动化设备普及的关键因素。医疗机构正在加速采用这些自动化系统,以消除人工重复操作并确保配药准确性,从而显着降低不良用药事件的风险。这种对安全的重视正在推动自动化工作流程中检验技术的应用,以防止配药错误。例如,美国卫生系统药剂师协会 (ASHP) 于 2024 年 5 月开展的「医院药房实践全国调查」显示,92.6% 的医院使用条码扫描来补充自动配药柜中的药品,这凸显了这些设备在维护严格的安全标准方面发挥的重要作用。
同时,人事费用上升和熟练药剂师短缺正对市场产生重大影响,迫使该行业采用机器人技术以维持业务连续性。随着服务需求与劳动力供应之间的差距不断扩大,各机构正在将日常配药任务自动化,以优化现有员工的工作效率。根据美国国家社区药剂师协会 (NCPA) 于 2024 年 10 月发布的《2024 年 NCPA 摘要》,67% 的独立社区药局业主正面临严重的员工短缺挑战。这种劳动力短缺正在推动自动化服务提供者的财务成长。例如,Omnicell 公司在 2025 年 2 月发布的 2024 财年财务报告中显示,其年度经常性收入为 5.8 亿美元,这印证了各机构越来越依赖自动化基础设施来缓解劳动力短缺的挑战。
实施所需的大量资本投入是全球药局自动化设备市场的一大障碍。机器人系统和自动配药柜的高昂初始成本构成了进入门槛,阻碍了其普及,尤其对于预算有限的独立药房和小规模医疗机构而言更是如此。此外,技术复杂性以及与现有医院资讯网路整合的相关成本进一步加剧了这一经济负担,导致许多潜在用户儘管面临营运方面的诸多益处,仍然选择推迟或放弃现代化改造计画。
这些财务限制的影响在近期行业数据中显而易见。根据美国国家社区药剂师协会 (NCPA) 发布的《2024 年报告摘要》,独立社区药局的毛利率将在 2023 年下降至 19.7%,创该报告发布十年以来的最低水准。在如此严峻的财务环境下,药局管理人员越来越难以证明昂贵自动化技术的投资收益(ROI) 的合理性。因此,资金短缺直接阻碍了药房在零售领域和资源有限的医院环境中的市场渗透,从而有效地抑制了该行业的潜在成长速度。
透过向去中心化自动化配药模式的转变,医药产业正在经历结构性转型。这种模式将大批量处方笺配药作业从零售柜檯转移到自动化微型仓配中心。这种中心辐射式配置利用工业机器人处理日常用药,从而减轻现场工作量,使药剂师能够专注于临床服务而非手动配药。大型连锁药局正积极寻求优化其集中处理能力,而这种转变正获得显着推动。根据沃尔格林于2025年5月发布的题为「扩展处方笺微型仓配网络」的新闻稿,该公司微型仓配中心的出货量同比增长24%,这表明这种集中式配药架构正在迅速扩张。
同时,采用基于云端的药房工作流程平台对于确保整个医疗保健系统的互通性和无缝资料交换至关重要。这些数位生态系统打破了传统的资讯孤岛,实现了跨多个医疗机构的即时库存可见性和统一的病患记录。行业领导者正积极利用这一趋势,建立完全互联的技术基础设施,以改善消费者的健康体验并简化后端营运。根据《连锁药局评论》(Chain Drug Review)2025年6月刊报导,CVS Health宣布将在未来10年内战略性投资200亿美元,以建立一个专注于推动系统范围内互通性和数位化互动的技术主导平台。
The Global Pharmacy Automation Devices Market is projected to expand from a valuation of USD 5.73 Billion in 2025 to USD 9.67 Billion by 2031, registering a Compound Annual Growth Rate (CAGR) of 9.11%. These electromechanical systems are designed to automate critical medication management processes, including storage, packaging, dispensing, and retrieval, thereby streamlining operations within hospital and retail environments. Market growth is primarily driven by the urgent need to reduce medication errors, manage surging prescription volumes, and enhance workforce productivity. Evidence of widespread acceptance is reflected in data from the American Society of Health-System Pharmacists, which noted in 2024 that 86.1% of hospitals utilized automated dispensing cabinets as the primary method for maintenance dose distribution.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 5.73 Billion |
| Market Size 2031 | USD 9.67 Billion |
| CAGR 2026-2031 | 9.11% |
| Fastest Growing Segment | Automated Medication Compounding Systems |
| Largest Market | North America |
Despite this positive trajectory, the market faces considerable hurdles due to the significant capital investment required for deployment. The prohibitive initial costs of robotic systems, along with the technical difficulties associated with integrating them into existing hospital information architectures, frequently discourage adoption by smaller healthcare institutions. Consequently, these financial and infrastructure-related challenges act as persistent barriers, limiting the market's reach in resource-constrained settings and impeding broader penetration.
Market Driver
The imperative to minimize medication errors and enhance patient safety serves as a primary catalyst for the adoption of pharmacy automation devices. Healthcare institutions are increasingly integrating these automated systems to eliminate manual redundancies and ensure dispensing accuracy, significantly reducing the risk of adverse drug events. This commitment to safety is driving the implementation of verification technologies within automated workflows to prevent distribution failures. For instance, the 'National Survey of Pharmacy Practice in Hospital Settings' by the American Society of Health-System Pharmacists in May 2024 revealed that 92.6% of hospitals employed barcode scanning while restocking automated dispensing cabinets, highlighting the pivotal role these devices play in upholding strict safety standards.
Simultaneously, the market is significantly influenced by rising labor costs and a shortage of skilled pharmacists, compelling the industry to deploy robotics to maintain operational continuity. As the gap between service demand and workforce availability widens, organizations are automating routine dispensing tasks to optimize the efficiency of existing staff. The '2024 NCPA Digest' published by the National Community Pharmacists Association in October 2024 indicated that 67% of independent community pharmacy owners faced substantial difficulty in filling staff positions. This workforce strain has fueled financial growth for automation providers; Omnicell, Inc., for example, reported an Annual Recurring Revenue of $580 million for the fiscal year ending 2024 in February 2025, underscoring the increasing reliance on automated infrastructure to mitigate labor challenges.
Market Challenge
The substantial capital expenditure required for implementation constitutes a severe obstruction to the Global Pharmacy Automation Devices Market. High upfront costs for robotic systems and automated dispensing cabinets create a prohibitive barrier to entry, particularly for independent pharmacies and smaller healthcare facilities operating on restricted budgets. This financial burden is compounded by the technical complexity and associated costs of integrating these systems with legacy hospital information networks, leading many potential adopters to delay or forgo modernization efforts despite the operational benefits.
The impact of these financial constraints is evident in recent industry data. According to the National Community Pharmacists Association (NCPA) 2024 Digest, the gross profit margin for independent community pharmacies fell to 19.7% in 2023, marking the lowest point in the report's ten-year history. Such constricted fiscal environments make it increasingly difficult for facility managers to justify the Return on Investment (ROI) for expensive automation technologies. Consequently, this lack of available capital directly stalls market penetration in the retail sector and resource-limited hospital settings, effectively capping the industry's potential growth rate.
Market Trends
The industry is witnessing a structural transformation through the shift toward decentralized automated dispensing models, which relocate high-volume prescription fulfillment from retail counters to automated micro-fulfillment centers. This hub-and-spoke configuration leverages industrial-grade robotics to process maintenance medications, thereby alleviating on-site workload constraints and allowing pharmacists to focus on clinical services rather than manual filling. This transition is gaining significant momentum among major pharmacy chains seeking to optimize centralized throughput capabilities. According to Walgreens, May 2025, in the 'Walgreens Expands Prescription Microfulfillment Network' press release, the company reported a 24% year-over-year increase in shipped volumes from its micro-fulfillment centers, highlighting the rapid scaling of this centralized dispensing architecture.
Simultaneously, the adoption of cloud-based pharmacy workflow platforms is becoming critical for ensuring interoperability and seamless data exchange across the healthcare continuum. These digital ecosystems dismantle traditional information silos, enabling real-time inventory visibility and unified patient records that span multiple care settings. Industry leaders are aggressively capitalizing on this trend to create fully connected technology infrastructures that enhance the consumer health experience and streamline backend operations. According to Chain Drug Review, June 2025, in the article 'CVS Health plans to spend $20B to enhance the consumer experience', CVS Health announced a strategic investment of $20 billion over the next decade to build a technology-driven platform focused on advancing system-wide interoperability and digital engagement.
Report Scope
In this report, the Global Pharmacy Automation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Pharmacy Automation Devices Market.
Global Pharmacy Automation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: